Anavex Life Sciences Corp. (AVXL) Stock Quote

Detailed Quote for Anavex Life Sciences Corp. (AVXL)

close 52 Week Information

52 Week High

February 15, 2011

Close: 3.90

52 Week Low

September 26, 2011

Close: 1.05

Today

Last Price
1.75

Change $
0.01

Change %
0.57%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
1.80

High
1.80

Low
1.70

Prev Close
1.74

Last Trade
2/10/12

Volume
18.78 k

52 Wk Hi
3.90

52 Wk Low
1.05

Market Cap
47.58 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
27,187,174

EPS (TTM)
-0.29

PE Ratio
N/A

close Exchange Information Listed On OTC Bulletin Board Consolidated (OTCBB) Exchange
OTCBB

News and Media for Anavex Life Sciences Corp. (AVXL)

Sector News | Topic News

News for AVXL

Wed, Dec 07, 2011

6:22 PM

Anavex Closes Private Placement - Newsfile

Mon, Nov 14, 2011

9:00 AM

Anavex successfully completes a Phase 1 clinical trial for ANAVEX 2-73 - PR Newswire

Wed, Oct 12, 2011

9:00 AM

Anavex appoints Dr. George Tidmarsh as Executive Director - PR Newswire

9:00 AM

Anavex appoints Dr. George Tidmarsh as Executive Director - Newsfile

Thu, Sep 15, 2011

9:56 AM

Anavex to present data on ANAVEX 2-73, lead compound for Alzheimer's disease, at Japan Neuroscience Society special symposium - PR Newswire

Tue, Dec 21, 2010

1:33 PM

Anavex files Phase I regulatory submission for ANAVEX 2-73 in Alzheimer's disease - Accesswire

Mon, Sep 27, 2010

2:17 PM

Anavex Life Sciences Corp.: Corporate Update - Newsfile

Wed, Aug 18, 2010

2:17 PM

Anavex Appoints Contract Research Organizations to Initiate Phase I/IIa Clinical Programs, Regulatory Strategies in Alzheimer's Disease - Newsfile

Thu, Aug 27, 2009

10:22 AM

ANAVEX reports sigma receptor review published in leading journal - Accesswire

Tue, Jun 16, 2009

10:20 AM

ANAVEX appoints Dr. Herve de Kergrohen as CEO to lead company through clinical trials and future growth - Accesswire

Thu, Apr 09, 2009

3:48 PM

Anavex receives $2.14 million capital injection - Accesswire

Wed, Feb 11, 2009

9:36 AM

Anavex appoints leading Alzheimer¿s disease expert Dr. Mark Smith to scientific advisory board - Accesswire

Mon, Feb 02, 2009

12:31 PM

Anavex Scales Up Synthesis of Anavex 2-73 for Phase 1 Alzheimer's Disease Study - Accesswire

More News for AVXL >>

Tags for Anavex Life Sciences Corp.

Research stocks or mutual funds related to Anavex Life Sciences Corp. by keywords or tags. Find companies that have a similar focus to AVXL. The keywords below have been associated to AVXL by either user submission or electronic means.

pharmaceutical branding cell apoptosis pharmaceutical publication pockels cells pharmaceutical investment apoptosis assays search firms executive search company estrogen receptor coattail investor human cell photo pharmaceutical software apoptosis detection executive human cell pharma companies pharmaceutical sales pharma consultants pharma financial executive search amyloid antibody t cell receptor biotech consultant pharmaceutical development board of directors governance board governance pharmaceutical consultant biotech Drugs executive search firms board of directors software apoptosis inhibitors inhibitors investor relations manager follicular dendritic cells board of directors compensation pharmaceutical consulting human cells pharmaceutical industry biotech investment board of directors responsibility biotech industry recruiting firms pharmaceutical studies biotech consultants pharmaceutical business development toxicity Healthcare development board of directors pharmaceutical marketing mba